Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults

Clinical trial NCT00671814 · COMPLETED

Trial details

NCT number: NCT00671814
Sponsor: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2008-01-06
Primary completion: 2008-06-06
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.